In a head-to-head study, three continuous glucose monitoring systems show different measurements in the same person, which may affect therapeutic decision-making.

Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump.

A new study published in Diabetes Technology and Therapeutics showed that one of the main causes of postprandial and ...

Glucose Sensor MarketThe global glucose sensor market is projected to witness substantial growth, reaching a valuation of USD 20,421.4 million by 2034, according to a recent report. The market, ...

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Nick Jonas has given a surprising update on his diabetes journey.The Jonas Brothers member was diagnosed with type 1 diabetes ...

According to Yogish C. Kudva, Division of Endocrinology, Diabetes, Nutrition, Mayo Clinic, Rochester, Minnesota, USA, and ...

Credit: Dexcom. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring ... to which the sensor transmits glucose ...

Dexcom’s newly FDA-cleared G7 15-Day CGM system marks a major leap forward ... between the Dexcom G7 and the G7 15-Day lies in the sensor wear duration and accuracy. The Dexcom G7 15-Day offers ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.